This study is a Double-blind, Randomized, Sham-controlled, Investigator-initiated trial. To explore the effectiveness of non-invasive inner ear electrical stimulation of the mastoid behind the ear in controlling auditory symptoms and dizziness in patients with Meniere's disease.
Patients with dizziness (Meniere's) only, who understand the nature of the study and are willing to participate voluntarily.
The frequency of the hearing loss is between 250 kHz and 1 kHz.
Patients with bilateral 500, 1000, and 2000 Hz hearing threshold averages within 65 dB HL
Patients who have received conventional pharmacotherapy for other dizziness conditions with a washout period of 2 months.
Patients with an otologic condition other than Meniere'ss (dizziness) (otitis media, profound hearing loss, hyperacusis, etc.).
Patients' conditions that may affect EEG measurements, such as a stroke, brain hemorrhage, or brain tumor.
Patients with kidney disease
Patients Have or have had a serious medical condition, such as cancer (including leukemia, blood cancers, epilepsy, and neuropsychiatric conditions).